Amphastar Pharmaceuticals filed required 13F reports with the SEC on June 6, 2026.
1 report, 1 independent
Updated Jun 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Amphastar Pharmaceuticals filed required 13F reports with the SEC on June 6, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Amphastar Pharmaceuticals
publicly traded American pharmaceutical company
Nothing else this week.
-
Securities and Exchange Commission
government agency of the Philippines
Related events
- Verus Financial Partners Inc. filed its required 13F report with the Securities and Exchange Commission on November 1, 2026.
- The Securities and Exchange Commission requires Form 13F filings for the iShares Bitcoin Trust ETF.
- S&P Global filed required reports with the SEC, concurrent with Jefferies Financial Group providing research reports and price targets on June 26, 2026.
- NewLake Capital Partners, Inc. filed Form 13F with the Securities and Exchange Commission.
- Leonard Rickey Investment Advisors P.L.L.C. filed its required 13F report with the Securities and Exchange Commission.